Let's explore where CBG is already making a difference, where it’s headed and what cannabis businesses can do to be prepared.

Even daily use of low-level cannabis does not have a negative impact on cognition in older adults, recent research finds.

CBD oil's popularity surges across wellness and pharmaceutical sectors, lauded for potential benefits like pain and anxiety ...

Four-time Grammy-winning vocalist and powerhouse producer, composer, and independent record label founder Erykah Badu is ...

Artelo reports favorable Phase 1 results for its FABP5 inhibitor, showing strong safety data and dose-dependent absorption in ...

The study, published in the American Journal of Preventive Medicine, revealed that teenage vaping of current ...

The study revealed an "alarming" surge in adolescent vaping of THC, CBD, and synthetic cannabinoids. Now, experts are calling ...

Teen vaping is changing fast — and not in a good way. A large national study found that more adolescents are vaping THC, CBD, ...

Novel research has revealed that adolescent vaping of current delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and ...

Investing.com -- Artelo Biosciences Inc (NASDAQ: ARTL) stock surged over 100% following favorable results from its first-in-human study evaluating ART26.12, a novel inhibitor of Fatty Acid Binding ...

Tennessee’s industry has persisted through a period like the Wild West, where retail products meet exploding demand in the gray legal area surrounding plants of the cannabis genus.

By targeting FABP5, ART26.12 modulates endogenous lipid signaling molecules that exert analgesic effects through established pathways, including TRPV1, PPAR alpha, and cannabinoid receptors, with ...